Alexander, J., Gurwith, M., Mendy, J., Vang, L., Manayani, D., Avanzini, J., … Mayall, T. (2012). Development of a HIV-1 vaccine using an orally-administered, replication-competent adenovirus serotype 4 vector expressing Env clade C glycoprotein. In RETROVIROLOGY (Vol. 9). BIOMED CENTRAL LTD.

Alexander, J., M. Gurwith, J. Mendy, L. Vang, D. Manayani, J. Avanzini, B. Guenther, et al. “Development of a HIV-1 vaccine using an orally-administered, replication-competent adenovirus serotype 4 vector expressing Env clade C glycoprotein.” In RETROVIROLOGY, Vol. 9. BIOMED CENTRAL LTD, 2012.

Alexander J, Gurwith M, Mendy J, Vang L, Manayani D, Avanzini J, et al. Development of a HIV-1 vaccine using an orally-administered, replication-competent adenovirus serotype 4 vector expressing Env clade C glycoprotein. In: RETROVIROLOGY. BIOMED CENTRAL LTD; 2012.

Alexander, J., et al. “Development of a HIV-1 vaccine using an orally-administered, replication-competent adenovirus serotype 4 vector expressing Env clade C glycoprotein.” RETROVIROLOGY, vol. 9, BIOMED CENTRAL LTD, 2012.

Alexander J, Gurwith M, Mendy J, Vang L, Manayani D, Avanzini J, Guenther B, Farness P, Haynes BF, Liao H, Montefiori DC, LaBranche CC, Mayall T. Development of a HIV-1 vaccine using an orally-administered, replication-competent adenovirus serotype 4 vector expressing Env clade C glycoprotein. RETROVIROLOGY. BIOMED CENTRAL LTD; 2012.